Insight

Daniel Peeper: Rational combination of cancer therapies with PD1 axis blockade

Photo taken from ae-info.org

Aug 1, 2024, 03:50

Daniel Peeper: Rational combination of cancer therapies with PD1 axis blockade

Daniel Peeper, Cancer Researcher at The Netherlands Cancer Institute, shared a post on X:

“Happy to share a Nature Reviews Cancer/Nature Reviews Immunology poster by Daniela Thommen and myself, showing new therapeutic approaches that are combined with PD1 blockade for synergistic clinical benefit, using mechanistic understanding of cancer–immune interactions.”

Additional information.
Source: Daniel Peeper/X

cancer cancer–immune interactions Daniel Peeper Daniela Thommen Nature Reviews Cancer Nature Reviews Immunology OncoDaily Oncology The Netherlands Cancer Institute

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage